Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: WE PHARMA, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-11 to 2023-01-31
Current total value of award: $477943.82
Description: TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF TESTING RESEARCH IN ST. LOUIS, MO.